BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 45326)

  • 1. Evidence for a strong non-adrenergic component in the motor transmission to the rabbit vas deferens.
    Adebanjo AO; Ambache N
    West Afr J Pharmacol Drug Res; 1979; 5(1):95-105. PubMed ID: 45326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenergic contribution to the motor transmission in the dog vas deferens.
    Adebanjo AO; Ambache N
    Arch Int Pharmacodyn Ther; 1978 Jun; 233(2):261-9. PubMed ID: 28703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of post-ganglionic motor transmission in vas deferens by indirectly acting sympathomimetic drugs.
    Ambache N; Dunk LP; Verney J; Zar MA
    J Physiol; 1972 Dec; 227(2):433-56. PubMed ID: 4345926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence against adrenergic motor transmission in the guinea-pig vas deferens.
    Ambache N; Zar MA
    J Physiol; 1971 Jul; 216(2):359-89. PubMed ID: 4397760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further evidence for adrenergic transmission in the human vas deferens.
    Anton PG; McGrath JC
    J Physiol; 1977 Dec; 273(1):45-55. PubMed ID: 23430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual effect of agmatine in the bisected rat vas deferens.
    Santos WC; Smaili SS; Jurkiewicz A; PiƧarro I; Garcez-do-Carmo L
    J Pharm Pharmacol; 2003 Mar; 55(3):373-80. PubMed ID: 12724044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological responses by different portions of guinea pig vas deferens circular muscle preparation.
    Minker E; Bartha C
    Acta Physiol Acad Sci Hung; 1981; 58(1):65-77. PubMed ID: 6123218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial natriuretic factor inhibits adrenergic and purinergic neurotransmission in the rabbit isolated vas deferens.
    Drewett JG; Trachte GJ; Marchand GR
    J Pharmacol Exp Ther; 1989 Jan; 248(1):135-42. PubMed ID: 2536425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional variation in the distribution of alpha-adrenoreceptors in the vas deferens of the rat.
    Vardolov L; Pennefather JN
    Arch Int Pharmacodyn Ther; 1976 Jun; 221(2):212-2. PubMed ID: 9037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations of presynaptic adrenoceptor theory: the characteristics of the effects of noradrenaline and phenoxybenzamine on stimulation-induced efflux of [3H]noradrenaline in vas deferens.
    Kalsner S
    J Pharmacol Exp Ther; 1980 Feb; 212(2):232-9. PubMed ID: 6101347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta2-adrenoceptor-mediated prejunctional facilitation and postjunctional inhibition of sympathetic neuroeffector transmission in the guinea pig vas deferens.
    Todorov LD; Clerkin R; Mihaylova-Todorova ST; Khoyi MA; Westfall DP
    J Pharmacol Exp Ther; 2001 Aug; 298(2):623-33. PubMed ID: 11454924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of the pre and post-synaptic alpha blocking activity of thymoxamine and its metabolites in the rat vas deferens (author's transl)].
    Roquebert J; Demichel P; Malek A; Canellas J
    J Pharmacol; 1981; 12(1):15-25. PubMed ID: 6111626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An inhibition of post-ganglionic motor transmission in the mammalian vas deferens by D-lysergic acid diethylamide.
    Ambache N; Dunk LP; Verney J; Zar MA
    J Physiol; 1973 Jun; 231(2):251-70. PubMed ID: 4352765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Action of dihydroergocristine at pre- and postsynaptic alpha-adrenoceptors in the rat isolated vas deferens].
    Roquebert J; Demichel P; Gomond P; Malek A
    J Pharmacol; 1983; 14(2):151-9. PubMed ID: 6134866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of histamine with adrenergic smooth muscle neurotransmission. I. Effects of histamine on smooth muscle contractions induced by exogenous or by endogenous noradrenaline.
    Todorov S; Zamfirova R
    Acta Physiol Pharmacol Bulg; 1982; 8(3):52-8. PubMed ID: 6303052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine receptor antagonism attenuates angiotensin II effects on adrenergic neurotransmission in the rabbit isolated vas deferens.
    Trachte GJ; Heller LJ
    J Pharmacol Exp Ther; 1990 May; 253(2):490-6. PubMed ID: 2159994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sidnofen-dependent pre- and postsynaptic activation of peripheral adrenergic transmission].
    Babskaia NE
    Eksp Klin Farmakol; 1992; 55(5):21-5. PubMed ID: 1339046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha1A-adrenoceptor mediated contraction of rat prostatic vas deferens and the involvement of ryanodine stores and Ca2+ influx stimulated by diacylglycerol and PKC.
    Burt RP; Chapple CR; Marshall I
    Br J Pharmacol; 1998 Jan; 123(2):317-25. PubMed ID: 9489621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to adrenergic alpha-blocking agents by twitch-like contraction following field stimulation in rabbit vas deferens.
    Nakanishi H; Enatsu C; Watanabe T
    Fukushima J Med Sci; 1977; 24(3-4):107-15. PubMed ID: 33111
    [No Abstract]   [Full Text] [Related]  

  • 20. Pre- and postsynaptic effects of p-tyramine and p-octopamine in the prostatic portion of the rat vas deferens.
    Celuch SM; Juorio AV
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul; 338(1):39-46. PubMed ID: 2907098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.